Replies to post #110955 on Vivos Inc (RDGL)

[sharkey1]

That's wonderful, I on imangin it itches. And he wants to scratch. That's why the cone of shame. Hope he gets well soon

[sharkey1]

I might add, she said the same thing happened to the first dog, This y90 with GEL works, people should be next.

[TruthFairy222]

Excellent, another canine saved from cancer!

This is expected, post treatment. The focus is, of course, the elimination of the sarcoma, and Moose's renewed life expectancy.

We will prevail.

[sharky]

All the tests have gone positive, should be nothing holding us back from major pharma interest. Cancer cured each time system has been used. Not many companies can say they have cured multiple subjects with cancer. Only a matter of time before we are valued at a proper valuation. Nice cheap pricing here could add up to a lifechanger with catalysts ahead IMO.


$RDGL

[samsamsamiam]

How are you diagnosing the treatment worked?
I’m a little curious about the radioactive seeds implanted and what prevents them from migrating out of an open would like that. I supppse putting his cone back on is a preventive measure to keep him from chewing that open wound.
The original tumor was already removed was it not?

Will be interesting to follow that case. From the dog owners point of view.


So is Moose Dog number two in their 5 dog study?

Richland WA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc reported that the second dog in a five-dog series was successfully treated yesterday with Y-90 IsoPet® at the University of Missouri.
Dr. Charlie Maitz, the University of Missouri veterinarian reported “The procedure today went really well. Because the tumor was oddly shaped, I ended up administering the remaining 0.02 ml in what looked to be the most underdosed region. I was happy with how the injections went. Our differential between the pre- and post- vial in the dose calibrator was 0.3 mCi, which fits well with our target injected dose. With the bandage on, our patient is already below our release criteria in terms of dose rate. He recovered well from anesthesia and will likely be discharging on Monday.”